Cincinnati, OHNCT07029009Now EnrollingIRB Ready

Maturity Onset Diabetes of the Young Clinical Trial in Cincinnati, OH

Access cutting-edge maturity onset diabetes of the young treatment through this phase 2 clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.

Sponsored by Mansa

Quick Self-Assessment

See if you qualify for this Cincinnati location

Preparing your pre-screening questions…

Expert Care in Cincinnati

Access maturity onset diabetes of the young specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related maturity onset diabetes of the young treatment provided free

Apply for This Cincinnati Location

Check if you qualify for this maturity onset diabetes of the young clinical trial in Cincinnati, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cincinnati

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cincinnati site if eligible
  4. 4Begin participation

About This Maturity Onset Diabetes of the Young Study in Cincinnati

The reason for this research study is to better understand the use of liraglutide, a commonly prescribed Type 2 diabetes medication, in patients with a diagnosis of maturity-onset diabetes of the young (MODY). The investigators are interested in better understanding the way that this drug affects the metabolism and hormone levels of a person with MODY. Many people with MODY report having gastrointestinal (GI) issues such as an upset stomach. Investigators also are interested in finding out if this drug will help with GI issues. If liraglutide does help with this symptom of MODY, the investigators want to know why this happens. If this drug is effective for participants, the investigators will use participants cells to make human induced pluripotent stem cell (iPSC). This means that the investigators will use participant cells to create what are called stem cells, which are cells in the body that are able to be told what their job is. Investigators will use these cells to see what happens in gastrointestinal (GI) tract.

Sponsor: Mansa

Who Can Participate

Inclusion Criteria

Diagnosis of MODY via genetic testing
HgbA1c \>6.5%

Exclusion Criteria

History of anaphylaxis to GLP-1 receptor agonists
Already taking GLP-1 receptor agonists
on medications within the stimulant class
have had bariatric surgery
personal or family history of cancer, especially medullary thyroid cancer
personal history of pancreatitis or pathogenic variants associated with increased risk of pancreatitis
known active kidney disease
severe hypoglycemia (glucose \< 50 mg/dL) within 3 months of study enrollment
HbA1c \> 10.0%
episode of diabetic ketoacidosis (DKA) in the past 3 months
are currently pregnant
BMI \< 18.5 kg/m2 and pediatric patients with BMI \< 5th percentile

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cincinnati?

Yes, this clinical trial (NCT07029009) has an active research site in Cincinnati, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Maturity Onset Diabetes of the Young Treatment Options in Cincinnati, OH

If you're searching for maturity onset diabetes of the young treatment options in Cincinnati, OH, this clinical trial (NCT07029009) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cincinnati research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced maturity onset diabetes of the young specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all maturity onset diabetes of the young clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Cincinnati, OH

See all essential tremor clinical trials recruiting in Cincinnati — not just this study.

Browse Essential Tremor Trials in Cincinnati →

Browse More Trials by Condition

Ready to Join in Cincinnati?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cincinnati, OH